Ophthalmic Drug Market Size Worth $60.3 Billion By 2028 | CAGR: 6.4%
Ophthalmic Drugs Industry Overview The global ophthalmic drugs market size is expected to reach USD 60.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. An increase in the prevalence of eye-related disorders, such as presbyopia, macular degeneration, and diabetic retinopathy , is one of the major drivers of the market. According to the American Academy of Ophthalmology, over 2.71 million people in the U.S. were affected by Primary Open-angle Glaucoma (POAG) in 2011, and the number is estimated to reach 7.3 million by 2050. Ophthalmic Drugs Market Segmentation Grand View Research has segmented the global ophthalmic drugs market on the basis of drug class, disease, dosage form, route of administration, product type, and region. Based on the Drugs Class Insights, the market is segmented into Antiallergy, Anti-VEGF Agents, Anti-inflammatory, Antiglaucoma, Others. The...